Sort   by:  
 Page size 
UnknownSirolimus-eluting stents with ultrathin struts versus everolimus-eluting stents for patients undergoing percutaneous coronary intervention: final three-year results of the TALENT trial.
Not available
S-EPMC10241281 | biostudies-literature
UnknownObinutuzumab pretreatment abrogates tumor lysis risk while maintaining undetectable MRD for venetoclax + obinutuzumab in CLL.
Not available
S-EPMC6306887 | biostudies-literature
UnknownReal-world experience with targeted therapy in patients with histiocytic neoplasms in the Netherlands and in Belgium.
Not available
S-EPMC12096411 | biostudies-literature
UnknownCOVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study.
Not available
S-EPMC8559135 | biostudies-literature
UnknownRisk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry.
Not available
S-EPMC6306365 | biostudies-literature
Sort   by:  
 Page size